Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S.
08:30am, Wednesday, 20'th Nov 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet to Present at Upcoming Investor Conferences
06:00am, Friday, 15'th Nov 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More
04:06pm, Tuesday, 12'th Nov 2024
NVIDIA, Insulet and Howmet Aerospace have been selected as the top picks with a high net income ratio.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:51am, Tuesday, 12'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
09:10am, Tuesday, 12'th Nov 2024
Insulet's third-quarter performance benefits from the continued high demand for Omnipod 5.
Insulet CEO on earnings, GLP-1 and election impact
04:59pm, Monday, 11'th Nov 2024
Jim Hollingshead, Insulet CEO, joins 'Closing Bell: Overtime' to discuss the Insulet earnings, Apple blood sugar testing app and more.
Buy, Sell, Or Hold Insulet (PODD) Stock?
09:42am, Monday, 11'th Nov 2024
Insulet stock (NASDAQ: PODD) surged nearly 10% on Friday, November 8, after the company posted an upbeat Q3 and raised its sales outlook. It reported sales of $544 million and adjusted earnings of $0.
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript
10:54pm, Thursday, 07'th Nov 2024
Insulet Corporation (PODD) Q3 2024 Earnings Call Transcript
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
06:30pm, Thursday, 07'th Nov 2024
Although the revenue and EPS for Insulet (PODD) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str
Insulet (PODD) Q3 Earnings and Revenues Top Estimates
06:21pm, Thursday, 07'th Nov 2024
Insulet (PODD) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.71 per share a year ago.
Insulet raises annual revenue forecast on strong demand for insulin pumps
05:44pm, Thursday, 07'th Nov 2024
Insulet raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps.
Insulet Stock Gains From Expansion Strategies, Innovation
11:05am, Monday, 04'th Nov 2024
PODD continues to drive increased awareness for Omnipod through its direct-to-consumer advertising campaign.
Stay Ahead of the Game With Insulet (PODD) Q3 Earnings: Wall Street's Insights on Key Metrics
10:22am, Monday, 04'th Nov 2024
Get a deeper insight into the potential performance of Insulet (PODD) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
06:00am, Friday, 01'st Nov 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet (PODD) Earnings Expected to Grow: Should You Buy?
11:05am, Thursday, 31'st Oct 2024
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
